Tran M Nguyen Selected Research

Tran M Nguyen Research Topics

Disease

16	Crohn Disease (Crohn's Disease) 01/2024 - 11/2016
11	Ulcerative Colitis 06/2024 - 11/2018
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2019
5	Infections 12/2020 - 11/2016
4	Inflammation (Inflammations) 01/2022 - 05/2018
4	Headache (Headaches) 02/2019 - 01/2017
3	Nausea 02/2019 - 01/2017
3	Vomiting 02/2019 - 01/2017
2	Enterocolitis 01/2022 - 01/2022
2	Necrosis 05/2020 - 02/2019
2	Abscess 02/2019 - 05/2018
2	Fistula 02/2019 - 05/2018
2	Marijuana Abuse (Cannabis Abuse) 11/2018 - 11/2018
2	Neck Pain (Cervicalgia) 11/2017 - 01/2017
2	Exanthema (Rash) 11/2017 - 01/2017
2	Abdominal Pain (Pain, Abdominal) 11/2017 - 01/2017
1	Hemorrhage 06/2024
1	Colitis 06/2024
1	Microscopic Colitis 01/2022
1	Enteritis 01/2022
1	Common Variable Immunodeficiency 01/2022
1	Sclerosing Cholangitis 12/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Fatigue 02/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2019
1	Herpes Zoster 01/2019
1	Dizziness (Lightheadedness) 11/2018
1	Leukopenia 05/2018
1	Pathologic Constriction (Stenosis) 05/2018
1	Arthralgia (Joint Pain) 05/2018
1	Weight Gain 11/2017
1	Collagenous Colitis 11/2017
1	Hyperhidrosis 01/2017
1	Sleepiness 01/2017
1	Lymphocytic Colitis 01/2017
1	Injection Site Reaction 11/2016

Drug/Important Bio-Agent (IBA)

4	Mesalamine (Mesalazine)FDA LinkGeneric 12/2020 - 01/2017
4	CytokinesIBA 01/2020 - 11/2016
3	vedolizumabIBA 01/2024 - 01/2022
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 11/2019
3	Interleukin-12 (IL 12)IBA 01/2024 - 11/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 05/2020
3	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 01/2017
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 05/2018
3	CannabinoidsIBA 01/2020 - 11/2018
3	Monoclonal AntibodiesIBA 12/2019 - 11/2016
3	AntibodiesIBA 12/2019 - 11/2016
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2018 - 05/2018
2	tofacitinibIBA 06/2024 - 01/2020
2	Infliximab (Remicade)FDA Link 06/2024 - 01/2022
2	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 12/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	IntegrinsIBA 01/2022 - 12/2020
2	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2021
2	Adalimumab (Humira)FDA Link 05/2020 - 11/2019
2	Janus KinasesIBA 01/2020 - 01/2019
2	Janus Kinase InhibitorsIBA 01/2020 - 01/2019
2	Ustekinumab (CNTO 1275)FDA Link 12/2019 - 11/2016
2	Interleukin-23 (Interleukin 23)IBA 12/2019 - 11/2016
2	briakinumabIBA 12/2019 - 11/2016
2	C-Reactive ProteinIBA 11/2018 - 11/2018
1	etrolizumabIBA 01/2024
1	InterleukinsIBA 01/2024
1	IpilimumabIBA 01/2022
1	Immunoglobulin G (IgG)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2019
1	CannabidiolIBA 11/2018
1	EndocannabinoidsIBA 11/2018
1	EnzymesIBA 05/2018
1	Biomarkers (Surrogate Marker)IBA 05/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Natalizumab (Tysabri)FDA Link 01/2018
1	Naltrexone (ReVia)FDA LinkGeneric 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 11/2017
1	Cholestyramine Resin (Questran)FDA LinkGeneric 01/2017
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2017
1	Beclomethasone (Beclometasone)FDA Link 01/2017

Therapy/Procedure

13	Therapeutics 06/2024 - 01/2017
5	Remission Induction 12/2020 - 11/2016
4	Biological Therapy 12/2020 - 05/2018
1	Ileostomy 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Fecal Microbiota Transplantation 01/2022
1	Off-Label Use 01/2022
1	Liver Transplantation 12/2020